1. Home
  2. BMEA vs CRNC Comparison

BMEA vs CRNC Comparison

Compare BMEA & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • CRNC
  • Stock Information
  • Founded
  • BMEA 2017
  • CRNC 2020
  • Country
  • BMEA United States
  • CRNC United States
  • Employees
  • BMEA N/A
  • CRNC N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • CRNC EDP Services
  • Sector
  • BMEA Health Care
  • CRNC Technology
  • Exchange
  • BMEA Nasdaq
  • CRNC Nasdaq
  • Market Cap
  • BMEA 145.0M
  • CRNC 132.5M
  • IPO Year
  • BMEA 2021
  • CRNC N/A
  • Fundamental
  • Price
  • BMEA $3.46
  • CRNC $12.55
  • Analyst Decision
  • BMEA Buy
  • CRNC Buy
  • Analyst Count
  • BMEA 13
  • CRNC 8
  • Target Price
  • BMEA $27.92
  • CRNC $9.16
  • AVG Volume (30 Days)
  • BMEA 414.8K
  • CRNC 3.4M
  • Earning Date
  • BMEA 03-31-2025
  • CRNC 02-06-2025
  • Dividend Yield
  • BMEA N/A
  • CRNC N/A
  • EPS Growth
  • BMEA N/A
  • CRNC N/A
  • EPS
  • BMEA N/A
  • CRNC N/A
  • Revenue
  • BMEA N/A
  • CRNC $244,065,000.00
  • Revenue This Year
  • BMEA N/A
  • CRNC N/A
  • Revenue Next Year
  • BMEA N/A
  • CRNC $5.96
  • P/E Ratio
  • BMEA N/A
  • CRNC N/A
  • Revenue Growth
  • BMEA N/A
  • CRNC N/A
  • 52 Week Low
  • BMEA $3.25
  • CRNC $2.34
  • 52 Week High
  • BMEA $19.36
  • CRNC $27.50
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 34.96
  • CRNC 46.65
  • Support Level
  • BMEA $3.25
  • CRNC $13.41
  • Resistance Level
  • BMEA $3.75
  • CRNC $15.13
  • Average True Range (ATR)
  • BMEA 0.24
  • CRNC 1.35
  • MACD
  • BMEA 0.00
  • CRNC -0.24
  • Stochastic Oscillator
  • BMEA 21.43
  • CRNC 24.03

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

Share on Social Networks: